These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23149207)

  • 1. Hypertrophic and ulcerated discoid lupus erythematosus.
    Green PJ; Pasternak S
    J Cutan Med Surg; 2012; 16(6):453-7. PubMed ID: 23149207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic lupus erythematosus treated successfully with acitretin as monotherapy.
    Al-Mutairi N; Rijhwani M; Nour-Eldin O
    J Dermatol; 2005 Jun; 32(6):482-6. PubMed ID: 16043925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination of antimalarial drugs mepacrine and chloroquine in therapy refractory cutaneous lupus erythematosus].
    von Schmiedeberg S; Rönnau AC; Schuppe HC; Specker C; Ruzicka T; Lehmann P
    Hautarzt; 2000 Feb; 51(2):82-5. PubMed ID: 10743578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs for discoid lupus erythematosus.
    Jessop S; Whitelaw DA; Delamere FM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD002954. PubMed ID: 19821298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus.
    Feldmann R; Salomon D; Saurat JH
    Dermatology; 1994; 189(4):425-7. PubMed ID: 7873836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of acitretin in disseminated discoid lupus erythematosus].
    Kamińska-Winciorek G; Brzezińska-Wcisło L; Wcisło-Dziadecka D; Syguła E
    Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):899-900. PubMed ID: 16327722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
    González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
    Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acitretin treatment in antimalarial-refractory/intolerant discoid lupus erythematosus: A prospective, open-label, uncontrolled study.
    Laosakul K; Chiewchanvit S; Chuamanochan M; Tovanabutra N
    Lupus; 2022 Apr; 31(5):575-581. PubMed ID: 35306922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic efficacy of oral aromatic retinoid in long-standing hypertrophic lupus erythematosus.
    Shimizu S; Yasui C; Kawasaki H; Tsuchiya K
    Acta Derm Venereol; 2004; 84(6):491-2. PubMed ID: 15844651
    [No Abstract]   [Full Text] [Related]  

  • 11. [Classification of dermatologic manifestations in lupus erythematosus].
    Francès C; Barete S; Ayoub N; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):33-44. PubMed ID: 12746657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for discoid lupus erythematosus.
    Jessop S; Whitelaw D; Jordaan F
    Cochrane Database Syst Rev; 2001; (1):CD002954. PubMed ID: 11279785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab.
    Ocon A; Avalos Sugastti E; Duffy N
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38890107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML; McCauliffe DP
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CHRONIC DISCOID ERYTHEMATOSUS (REPORT ON 69 CASES OVER A PERIOD OF 6 YEARS FROM THE VIEWPOINT OF OPTIMUM THERAPY)].
    BORC K
    Cesk Dermatol; 1963 Aug; 38():293-7. PubMed ID: 14085999
    [No Abstract]   [Full Text] [Related]  

  • 16. [Four cases of photopheresis treatment for cutaneous lupus erythematosus refractory to standard therapy].
    Morruzzi C; Liu V; Bohbot A; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2009 Dec; 136(12):861-7. PubMed ID: 20004310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous hypertrophic lupus erythematosus: a challenging histopathologic diagnosis in the absence of clinical information.
    Arps DP; Patel RM
    Arch Pathol Lab Med; 2013 Sep; 137(9):1205-10. PubMed ID: 23991731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of discoid lupus erythematosus, polymorphous photodermatosis and rosacea with Triquin--a combination of 3 anti-malarials].
    FREDRIKSSON T; LODIN A; ROSENGREN S
    Sven Lakartidn; 1962 Oct; 59():2858-62. PubMed ID: 13959402
    [No Abstract]   [Full Text] [Related]  

  • 20. Innovative management of lupus erythematosus.
    Knott HM; Martínez JD
    Dermatol Clin; 2010 Jul; 28(3):489-99. PubMed ID: 20510759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.